EpiPen and EpiPen Jr. Recall – Prescribed from 12/17/2015 through 7/1/2016

Growing Child Pediatrics

Dear Patients,

Please note the recall for the following EpiPen and EpiPen Jr. products prescribed from 12/17/2015 through 7/1/2016 (Product/Dosage, NDC Number, Lot Number, Expiration Date):

  • EpiPen Jr Auto-Injector, 0.15 mg 49502-501-02 5GN767 April 2017
  • EpiPen Jr Auto-Injector, 0.15 mg 49502-501-02 5GN773 April 2017
  • EpiPen Auto-Injector, 0.3 mg 49502-500-02 5GM631 April 2017
  • EpiPen Auto-Injector, 0.3 mg 49502-500-02 5GM640 May 2017
  • EpiPen Jr Auto-Injector, 0.15 mg 49502-501-02 6GN215 September 2017
  • EpiPen Auto-Injector, 0.3 mg 49502-500-02 6GM082 September 2017
  • EpiPen Auto-Injector, 0.3 mg 49502-500-02 6GM072 September 2017
  • EpiPen Auto-Injector, 0.3 mg 49502-500-02 6GM081 September 2017
  • EpiPen Auto-Injector, 0.3 mg 49502-500-02 6GM088 October 2017
  • EpiPen Auto-Injector, 0.3 mg 49502-500-02 6GM199 October 2017
  • EpiPen Auto-Injector, 0.3 mg 49502-500-02 6GM091 October 2017
  • EpiPen Auto-Injector, 0.3 mg 49502-500-02 6GM198 October 2017
  • EpiPen Auto-Injector, 0.3 mg 49502-500-02 6GM087 October 2017

For further assistance, EpiPen users can contact Mylan at 800-796-9526 or email customer service at customer.service@mylan.com.  EpiPens are made by Meridian Medical Technologies, a subsidiary of Pfizer.

More information about today’s announcement is available at the FDA website.